XML 65 R50.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule of Loss Before Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Domestic $ (4,073) $ (596)
Foreign (121) 376
Total $ (4,194) [1] $ (220) [2]
[1] CVD Materials segment includes loss on sale of Tantaline of $0.2 million and an impairment charge related to MesoScribe fixed assets of $0.1 million.
[2] Includes other income related to ERCs of $1,103, $303 and $123 for the CVD, SDC and Materials segments, respectively.